Why this ASX medical technology share surged 43% higher today

The Medadvisor Ltd (ASX: MDR) share price is surging higher today after the company provided an update on the role it is playing in the coronavirus outbreak.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medadvisor Ltd (ASX: MDR) share price is surging higher today after the company provided an update on the role it is playing in the coronavirus outbreak.

After rocketing as much as 42.86% higher to $0.45 in early afternoon trade, MedAdvisor shares are now sitting at $0.39 at the time of writing, up 23.81%.

MedAdvisor is an Australian software systems developer. The company has a free app that connects to pharmacy dispensing systems to automatically retrieve medication records and also links to a training, information and reminder system to ensure correct medication use.

What did MedAdvisor announce today?

Today, MedAdvisor announced that it will enable Australian pharmacies to receive and process requests for medication delivery through its MedAdvisor App. The company will also offer pharmacies a temporary discount to the cost of its messaging service to all of their patients and enable patients to order from home.

Additionally, MedAdvisor will provide any pharmacies that are not a current customer an initial two month free trial of its platform. Currently, 60% of all pharmacies throughout Australia use its service.

How MedAdvisor can help the current healthcare crisis

MedAdvisor noted that it is set to play a crucial role in facilitating pharmacy home delivery following recent Federal Government funding. Last week, the Government announced it will provide $25 million to support pharmacies to home deliver medications, ensuring that isolated people can get the pharmaceutical items that they require by filling in their prescriptions remotely.

MedAdvisor further noted that patients have the option to remotely order prescriptions from a GP via its app. By pre-ordering in advance, this improves pharmacy workflow by helping pharmacies to more efficiently manage stock and also takes some burden off a stretched GP system.

In addition, Australian pharmacies can send or receive messages to patients through the MedAdvisor App and its partner apps provided by a range of Australian pharmacy chains including Amcal and Terry White.

Strong increase in ordering platform over the past week

MedAdvisor noted a significant increase in orders per pharmacy over the past week, particularly in the last 2 days.

To date, 57% of orders through the company's platform occur outside of normal business hours and MedAdvisor is expecting the volume of orders to increase significantly.

Recap of recent financial results

At the end of February, MedAdvisor reported its half year FY 2020 results, revealing operating revenue of $4.4 million, up by 14.4% on the prior corresponding period of 1H19.

Gross profit increased 14.4% to $3.9 million during the period, while gross margins remained stable at 87.6%. MedAdvisor commented that the international markets in which it operates represent a significant opportunity for growth.

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has recommended MedAdvisor. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »